These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38405302)

  • 1. Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma (HCC) With Single Photon Emission Computed Tomography (SPECT) Functional Treatment Planning in Patients With Advanced Hepatic Cirrhosis.
    Kirichenko A; Uemura T; Liang Y; Hasan S; Abel S; Renz P; Shamsesfandabadi P; Carpenter J; Yin Y; Thai N
    Adv Radiat Oncol; 2024 Feb; 9(2):101367. PubMed ID: 38405302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional Liver Imaging and Dosimetry to Predict Hepatotoxicity Risk in Cirrhotic Patients With Primary Liver Cancer.
    Schaub SK; Apisarnthanarax S; Price RG; Nyflot MJ; Chapman TR; Matesan M; Vesselle HJ; Bowen SR
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1339-1348. PubMed ID: 30170100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma with child Pugh-A Cirrhosis treated with stereotactic body radiotherapy.
    Hasan S; Thai N; Uemura T; Kudithipudi V; Renz P; Abel S; Kirichenko AV
    World J Gastrointest Surg; 2017 Dec; 9(12):256-263. PubMed ID: 29359031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic Body Radiotherapy Based on
    Kai Y; Toya R; Saito T; Matsuyama T; Fukugawa Y; Shiraishi S; Shimohigashi Y; Oya N
    In Vivo; 2020; 34(6):3583-3588. PubMed ID: 33144471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional Radiation Dose-Response Modeling of Functional Liver in Hepatocellular Carcinoma Patients With Longitudinal Sulfur Colloid SPECT/CT: A Proof of Concept.
    Price RG; Apisarnthanarax S; Schaub SK; Nyflot MJ; Chapman TR; Matesan M; Vesselle HJ; Bowen SR
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1349-1356. PubMed ID: 29932945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential hepatic avoidance radiation therapy: Proof of concept in hepatocellular carcinoma patients.
    Bowen SR; Saini J; Chapman TR; Miyaoka RS; Kinahan PE; Sandison GA; Wong T; Vesselle HJ; Nyflot MJ; Apisarnthanarax S
    Radiother Oncol; 2015 May; 115(2):203-10. PubMed ID: 25934165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic body radiotherapy used as a bridge to liver transplant in patients with hepatocellular carcinoma and Child-Pugh score ≥8 cirrhosis.
    Gresswell S; Tobillo R; Hasan S; Uemura T; Machado L; Thai N; Kirichenko A
    J Radiosurg SBRT; 2018; 5(4):261-267. PubMed ID: 30538886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Accelerated Hypofractionation and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma Patients With Varying Degrees of Hepatic Impairment.
    Nabavizadeh N; Waller JG; Fain R; Chen Y; Degnin CR; Elliott DA; Mullins BT; Patel IA; Dyer BA; Fakhoury K; Naugler WE; Farsad K; Tanyi JA; Fuss M; Thomas CR; Hung AY
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):577-585. PubMed ID: 29413273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma in Patients With Child-Pugh B or C Cirrhosis.
    Lee P; Ma Y; Zacharias I; Bozorgzadeh A; Wilson S; Foley K; Rava P; Masciocchi M; Ding L; Bledsoe J; Fitzgerald TJ; Sioshansi S
    Adv Radiat Oncol; 2020; 5(5):889-896. PubMed ID: 33083650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma: High Rates of Local Control With Low Toxicity.
    Baumann BC; Wei J; Plastaras JP; Lukens JN; Damjanov N; Hoteit M; Hsu C; Levine M; Mondschein J; Nadolski G; Olthoff K; Reiss KA; Rosen M; Siegelman E; Metz JM; Ben-Josef E
    Am J Clin Oncol; 2018 Nov; 41(11):1118-1124. PubMed ID: 29553972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic body radiation therapy in hepatocellular carcinoma: Optimal treatment strategies based on liver segmentation and functional hepatic reserve.
    Wang PM; Chung NN; Hsu WC; Chang FL; Jang CJ; Scorsetti M
    Rep Pract Oncol Radiother; 2015; 20(6):417-24. PubMed ID: 26696781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT).
    Scorsetti M; Comito T; Cozzi L; Clerici E; Tozzi A; Franzese C; Navarria P; Fogliata A; Tomatis S; D'Agostino G; Iftode C; Mancosu P; Ceriani R; Torzilli G
    J Cancer Res Clin Oncol; 2015 Jul; 141(7):1301-9. PubMed ID: 25644863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional liver-image guided hepatic therapy (FLIGHT): A technique to maximize hepatic functional reserve.
    Furukawa Y; Long DE; Ellsworth SG
    Med Dosim; 2020 Summer; 45(2):117-120. PubMed ID: 31439270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-time Magnetic Resonance-guided Liver Stereotactic Body Radiation Therapy: An Institutional Report Using a Magnetic Resonance-Linac System.
    Feldman AM; Modh A; Glide-Hurst C; Chetty IJ; Movsas B
    Cureus; 2019 Sep; 11(9):e5774. PubMed ID: 31723533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology.
    Chiesa C; Mira M; Maccauro M; Spreafico C; Romito R; Morosi C; Camerini T; Carrara M; Pellizzari S; Negri A; Aliberti G; Sposito C; Bhoori S; Facciorusso A; Civelli E; Lanocita R; Padovano B; Migliorisi M; De Nile MC; Seregni E; Marchianò A; Crippa F; Mazzaferro V
    Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1718-1738. PubMed ID: 26112387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of CyberKnife stereotactic body radiation therapy for hepatocellular carcinoma on hepatic toxicity.
    Liang P; Huang C; Liang SX; Li YF; Huang SX; Lian ZP; Liu JM; Tang Y; Lu HJ
    Onco Targets Ther; 2016; 9():7169-7175. PubMed ID: 27920555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic utility of 90Y radioembolization dosimetry based on fusion 99mTc-macroaggregated albumin-99mTc-sulfur colloid SPECT.
    Lam MG; Goris ML; Iagaru AH; Mittra ES; Louie JD; Sze DY
    J Nucl Med; 2013 Dec; 54(12):2055-61. PubMed ID: 24144563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional image-guided stereotactic body radiation therapy planning for patients with hepatocellular carcinoma.
    Tsegmed U; Kimura T; Nakashima T; Nakamura Y; Higaki T; Imano N; Doi Y; Kenjo M; Ozawa S; Murakami Y; Awai K; Nagata Y
    Med Dosim; 2017 Summer; 42(2):97-103. PubMed ID: 28433483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic outcome and related predictors of stereotactic body radiotherapy for small liver-confined HCC: a systematic review and meta-analysis of observational studies.
    Long Y; Liang Y; Li S; Guo J; Wang Y; Luo Y; Wu Y
    Radiat Oncol; 2021 Apr; 16(1):68. PubMed ID: 33832536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Toxicity of Stereotactic Body Radiotherapy for Early to Advanced Stage Hepatocellular Carcinoma - Initial Experience From an Australian Liver Cancer Service.
    Liu HY; Lee Y; McLean K; Leggett D; Hodgkinson P; Fawcett J; Mott R; Stuart K; Pryor D
    Clin Oncol (R Coll Radiol); 2020 Oct; 32(10):e194-e202. PubMed ID: 32345457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.